Sabejon, Eduardo E.
HRN: 21-98-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2023
CIPROFLOXACIN 500MG (TAB)
08/09/2023
08/11/2023
PO
500mgtab
Bid
Acute Pyelonephritis
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes